Post-hoc long-read sequencing links leukemic mutation status to single-cell transcriptomes
bioRxiv · · Preprint
Post-hoc long-read sequencing links leukemic mutation status to single-cell transcriptomes
Papavasileiou, Wu + 7 more
The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.
Read the brief in JClub →Related in JClub
Blood · · Clinical Trial, Phase I
Ziftomenib combined with venetoclax and azacitidine achieves a 46% composite complete remission rate in relapsed/refractory NPM1-mutated AML patients at the 600 mg dose.
Blood · · Journal Article
CALR-mutated myeloproliferative neoplasms originate mainly from expansion of Vwf-positive, platelet-biased hematopoietic stem cells, with CALRdel52 mutations showing greater amplification.
Blood · · Clinical Trial, Phase II
Venetoclax combined with pediatric-inspired chemotherapy achieves a 91% remission rate and improves survival in adolescents and adults with newly diagnosed Ph-negative ALL.
- Open access
- 1 cites